Abstract
Glycosylphosphatidylinositol (GPI) moieties consist of a hydrophobic core (two to three fatty acids attached to phosphatidylinositol) continued by a chain of five hexoses (the glycolinker) that is covalently linked via phosphoethanolamine to the C-terminal amino acid of a long list of mammalian proteins. This glycolipid moiety imparts characteristic membrane properties (diffusion, lateral mobility and clustering) to proteins and the glycolinker component constitutes a molecular motif recognized by lectins, cytokines and bacterial toxins. Due to the saturated acyl chains of its core lipids, GPIs preferentially insert in sphingolipid-rich domains of the plasma membrane outer leaflet, and the capacity of GPIanchored proteins to participate in transmembrane signalling depends on this property. GPI-anchored proteins can be made to associate with membranes and thus offer a therapeutic potential in tumor vaccine preparation and complement protection. Research on the role of GPI-anchored proteins in membrane structure and function has fruitfully contributed to the elaboration of today ’ s prevailing concepts of membrane organization.
Keywords: concanavalin A, tumor necrosis factor alpha, CD59 protein, insulin-receptor substrate, Bacterial Toxins
Current Organic Chemistry
Title: Functional and Structural Roles of GPI Moieties in Mammalian Plasma Membranes
Volume: 11 Issue: 7
Author(s): Daniel C. Hoessli, Sebastien Tauzin, Nasir-ud-Din and Bettina Borisch
Affiliation:
Keywords: concanavalin A, tumor necrosis factor alpha, CD59 protein, insulin-receptor substrate, Bacterial Toxins
Abstract: Glycosylphosphatidylinositol (GPI) moieties consist of a hydrophobic core (two to three fatty acids attached to phosphatidylinositol) continued by a chain of five hexoses (the glycolinker) that is covalently linked via phosphoethanolamine to the C-terminal amino acid of a long list of mammalian proteins. This glycolipid moiety imparts characteristic membrane properties (diffusion, lateral mobility and clustering) to proteins and the glycolinker component constitutes a molecular motif recognized by lectins, cytokines and bacterial toxins. Due to the saturated acyl chains of its core lipids, GPIs preferentially insert in sphingolipid-rich domains of the plasma membrane outer leaflet, and the capacity of GPIanchored proteins to participate in transmembrane signalling depends on this property. GPI-anchored proteins can be made to associate with membranes and thus offer a therapeutic potential in tumor vaccine preparation and complement protection. Research on the role of GPI-anchored proteins in membrane structure and function has fruitfully contributed to the elaboration of today ’ s prevailing concepts of membrane organization.
Export Options
About this article
Cite this article as:
Hoessli C. Daniel, Tauzin Sebastien, Nasir-ud-Din and Borisch Bettina, Functional and Structural Roles of GPI Moieties in Mammalian Plasma Membranes, Current Organic Chemistry 2007; 11 (7) . https://dx.doi.org/10.2174/138527207780598783
DOI https://dx.doi.org/10.2174/138527207780598783 |
Print ISSN 1385-2728 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5348 |
Call for Papers in Thematic Issues
Catalytic C-H bond activation as a tool for functionalization of heterocycles
The major topic is the functionalization of heterocycles through catalyzed C-H bond activation. The strategies based on C-H activation not only provide straightforward formation of C-C or C-X bonds but, more importantly, allow for the avoidance of pre-functionalization of one or two of the cross-coupling partners. The beneficial impact of ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Management of Incidental Findings in the Era of Next-generation Sequencing
Current Genomics Targeting Ion Channels for New Strategies in Cancer Diagnosis and Therapy
Current Clinical Pharmacology Advances in Research of Schiff-Base Metal Complexes as Potent Antioxidants
Current Medicinal Chemistry Selective Cyclooxygenase-2 Inhibitors and Non-small Cell Lung Cancer
Current Medicinal Chemistry The Significance of Ubiquitin Proteasome Pathway in Cancer Development
Recent Patents on Anti-Cancer Drug Discovery Hypnotic Profile of Imines from Benzimidazole Chalcones: Mechanism of Synthesis, DFT Studies and in silico Screening
Central Nervous System Agents in Medicinal Chemistry Advances in Transient Receptor Potential Vanilloid-2 Channel Expression and Function in Tumor Growth and Progression
Current Protein & Peptide Science The Effect of Chemotherapy/Radiotherapy on Cancerous Pattern Recognition by NK Cells
Current Medicinal Chemistry Dysfunction of Mitochondrial ATP Production As a Target for Personalized Cancer Therapy
Current Pharmacogenomics and Personalized Medicine Editorial (Thematic Issue: Immunophilins, Protein Chemistry and Cell Biology of a Promising New Class of Drug Targets – Part II)
Current Molecular Pharmacology Cytogenetic and Molecular Abnormalities in Myelodysplastic Syndrome
Current Molecular Medicine Metal Containing Chloroquinolines: Beyond Hit and Miss Antimalarial Efficacy to Solid Science
Mini-Reviews in Medicinal Chemistry Preface
Current Pharmaceutical Biotechnology Lifestyle Factors and MicroRNAs: A New Paradigm in Cancer Chemoprevention
MicroRNA Beyond the "Lock and Key" Paradigm: Targeting Lipid Rafts to Induce the Selective Apoptosis of Cancer Cells
Current Medicinal Chemistry Immune Responses to Therapeutic Proteins in Humans - Clinical Significance, Assessment and Prediction
Current Pharmaceutical Biotechnology The Use of Cytokines and Chemokines in the Cancer Immunotherapy
Recent Patents on Anti-Cancer Drug Discovery Modulation of TRAIL-Induced Apoptosis by HDAC Inhibitors
Current Cancer Drug Targets Dynamic Crosstalk between GlcNAcylation and Phosphorylation: Roles in Signaling, Transcription and Human Disease
Current Signal Transduction Therapy Therapeutic Intervention in Cancer and Chronic Viral Infections: Antibody Mediated Manipulation of PD-1/PD-L1 Interaction
Reviews on Recent Clinical Trials